Canada vs Iran, Islamic Republic of: Previously treated cases tested for RR-/MDR-TB
Canada
88.0%
in 2024
Iran, Islamic Republic of
89.0%
in 2024
Canada rank
90th
Iran, Islamic Republic of rank
87th
Previously treated cases tested for RR-/MDR-TB over time
- Canada
- Iran, Islamic Republic of
How they compare
Iran, Islamic Republic of currently reports 89.0% against 88.0% in Canada, a difference of 1.0%.
The two have swapped places 3 times across 14 shared years of data; in 2006 it was Canada ahead.
Canada ranks 90th and Iran, Islamic Republic of ranks 87th of 180 countries.
Across the 3 decades both report, Canada averaged higher in 2 and Iran, Islamic Republic of in 1.
Head to head by decade
| Decade | Canada | Iran, Islamic Republic of | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 79.0% | 24.0% | 55.0% | Canada |
| 2010s | 76.3% | 45.4% | 30.9% | Canada |
| 2020s | 78.8% | 82.2% | 3.5% | Iran, Islamic Republic of |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Canada or Iran, Islamic Republic of?
- Iran, Islamic Republic of, at 89.0% against 88.0% in Canada as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Canada and Iran, Islamic Republic of?
- 1.0%, with Iran, Islamic Republic of ahead.
- How many years of comparable data are there for Canada and Iran, Islamic Republic of?
- 14 years are reported by both, from 2006 to 2024.
- How do Canada and Iran, Islamic Republic of rank globally for previously treated cases tested for rr-/mdr-tb?
- Canada ranks 90th and Iran, Islamic Republic of ranks 87th of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.